-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
MiNK Therapeutics, Inc. quarterly and annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2020 to Q1 2025.
- MiNK Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $576.
- MiNK Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $10,819,986.
- MiNK Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $407,173, a 162% decline from 2022.
- MiNK Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $155,599, a 100% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)